Tags : PsA

Biosimilars Biotech

Sandoz’s Erelzi (etanercept, biosimilar) Receives Health Canada Approval for Psoriatic

Shots: The approval is based on P-III EGALITY study results assessing Erelzi (etanercept) vs Enbrel, evaluating its PK, safety and efficacy On 17 Jan, 2019 Sandoz received NOC from Health Canada for Erelzi for reducing signs and symptoms, inhibiting the progression of structural damage of active arthritis & improving physical function in adults with PsA, […]Read More